Programming and Regulation of Metabolic Homeostasis by HDAC11

被引:78
|
作者
Sun, Lei [1 ,2 ]
de Evsikova, Caralina Marin [3 ]
Bian, Ka [1 ,2 ]
Achille, Alexandra [4 ]
Telles, Elphine [1 ]
Pei, Huadong [1 ,2 ]
Seto, Edward [1 ,2 ]
机构
[1] George Washington Univ, Canc Ctr, Washington, DC 20052 USA
[2] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20052 USA
[3] Morsani Coll Med, Dept Mol Med, Tampa, FL USA
[4] Univ S Florida, Moffitt Canc Ctr, Tampa, FL 33612 USA
来源
EBIOMEDICINE | 2018年 / 33卷
关键词
HDAC11; Obesity; Metabolic syndrome; Hepatic steatosis; UCP1; CPT1; Adiponectin; BROWN ADIPOSE-TISSUE; FATTY-ACID SYNTHESIS; DIET-INDUCED OBESITY; HISTONE DEACETYLASES; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; LIVER; EXPRESSION; MICE; INHIBITOR;
D O I
10.1016/j.ebiom.2018.06.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Histone deacetylases (HDACs) are enzymes that regulate protein functions by catalyzing the removal of acetyl and acyl groups from lysine residues. They play pivotal roles in governing cell behaviors and are indispensable in numerous biological processes. HDAC11. the last identified and sole member of class IV HDACs, was reported over a decade ago. However, its physiological function remains poorly understood. Here, we report that HDACI 1 knockout mice are resistant to high-fat diet-induced obesity and metabolic syndrome, suggesting that HDAC11 functions as a crucial metabolic regulator. Depletion of HDAC11 significantly enhanced insulin sensitivity and glucose tolerance, attenuated hypercholesterolemia, and decreased hepatosteatosis and liver damage. Mechanistically, HDAC11 deficiency boosts energy expenditure through promoting thermogenic capacity, which attributes to the elevation of uncoupling protein 1 (UCP1) expression and activity in brown adipose tissue. Moreover, loss of HDACI 1 activates the adiponectin-AdipoR-AMPK pathway in the liver, which may contribute to a reversal in hepatosteatosis. Overall, our findings distinguish HDAC11 as a novel regulator of obesity, with potentially important implications for obesity-related disease treatment. (C) 2018 The Authors. Published by Elsevier B.V.
引用
收藏
页码:157 / 168
页数:12
相关论文
共 50 条
  • [1] HDAC11, an emerging therapeutic target for metabolic disorders
    Chen, Huizhen
    Xie, Chunguang
    Chen, Qiu
    Zhuang, Shougang
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [2] The role of HDAC11 in obesity-related metabolic disorders: A critical review
    Yang, Hong
    Chen, Lingling
    Sun, Qian
    Yao, Fangyao
    Muhammad, Saeed
    Sun, Chao
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (08) : 5582 - 5591
  • [3] HDAC11 is a novel drug target in carcinomas
    Deubzer, Hedwig E.
    Schier, Marie C.
    Oehme, Ina
    Lodrini, Marco
    Haendler, Bernard
    Sommer, Anette
    Witt, Olaf
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (09) : 2200 - 2208
  • [4] HDAC11 inhibition triggers bimodal thermogenic pathways to circumvent adipocyte catecholamine resistance
    Robinson, Emma L.
    Bagchi, Rushita A.
    Major, Jennifer L.
    Bergman, Bryan C.
    Matsuda, Jennifer L.
    McKinsey, Timothy A.
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (19)
  • [5] Proliferative status regulates HDAC11 mRNA abundance in nontransformed fibroblasts
    Bagui, Tapan K.
    Sharma, Savitha S.
    Ma, Le
    Pledger, W. Jack
    CELL CYCLE, 2013, 12 (21) : 3433 - 3441
  • [6] The adipocyte as an endocrine organ in the regulation of metabolic homeostasis
    Harwood, H. James, Jr.
    NEUROPHARMACOLOGY, 2012, 63 (01) : 57 - 75
  • [7] HDAC11: A novel target for improved cancer therapy
    Liu, Yan
    Tong, Xuechao
    Hu, Weina
    Chen, Da
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 166
  • [8] Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells
    Cheng, Fengdong
    Lienlaf, Maritza
    Perez-Villarroel, Patricio
    Wang, Hong-Wei
    Lee, Calvin
    Woan, Karrune
    Woods, David
    Knox, Tessa
    Bergman, Joel
    Pinilla-Ibarz, Javier
    Kozikowski, Alan
    Seto, Edward
    Sotomayor, Eduardo M.
    Villagra, Alejandro
    MOLECULAR IMMUNOLOGY, 2014, 60 (01) : 44 - 53
  • [9] Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma
    Huang, Renhong
    Zhang, Xiaowei
    Sophia, Sadia
    Min, Zhijun
    Liu, Xiaojian
    ANTI-CANCER DRUGS, 2018, 29 (04) : 364 - 370
  • [10] HDAC11 deletion reduces fructose-induced cardiac dyslipidemia, apoptosis and inflammation by attenuating oxidative stress injury
    Fan, Xiao-Di
    Wan, Lan-Lan
    Duan, Man
    Lu, Shan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 503 (02) : 444 - 451